BNT logo

BNT

Brookfield Wealth Solutions Ltd. Class A Exchangeable Limited

$45.77
-$0.75(-1.61%)
74
Overall
85
Value
90
Tech
47
Quality
Market Cap
$14.37B
Volume
53.07K
52W Range
$29.13 - $49.44
Target Price
$36.00

Latest News for BNT

Deutsche Bank Keeps Their Hold Rating on Brenntag AG (0MPT)
TipRanks Auto-Generated Intelligence Newsdesk2 days agoDec 12, 2025

In a report released today, Tristan Lamotte from Deutsche Bank maintained a Hold rating on Brenntag AG, with a price target of €46.00. According to......

BioNTech SE (BNTX) Gets a Buy from Berenberg Bank
TipRanks Auto-Generated Intelligence Newsdesk3 days agoDec 11, 2025

In a report released yesterday, Harry Gillis from Berenberg Bank maintained a Buy rating on BioNTech SE, with a price target of $155.00. The compan......

Citi Sticks to Their Buy Rating for BioNTech SE (BNTX)
TipRanks Auto-Generated Intelligence Newsdesk4 days agoDec 10, 2025

In a report released yesterday, Geoff Meacham from Citi maintained a Buy rating on BioNTech SE, with a price target of $145.00. The company’s share......

Brenntag AG (0MPT) Receives a Hold from Berenberg Bank
TipRanks Auto-Generated Intelligence Newsdesk4 days agoDec 10, 2025

Berenberg Bank analyst Carl Raynsford maintained a Hold rating on Brenntag AG yesterday and set a price target of €48.00. The company’s shares clos......

BioNTech and BMS Report Promising Phase 2 Results for TNBC Treatment
TipRanks Auto-Generated Newsdesk5 days agoDec 09, 2025

BioNTech SE ( ($BNTX) ) has issued an announcement. On December 9, 2025, BioNTech SE and Bristol Myers Squibb announced interim results from a glob......

Jefferies Sticks to Its Sell Rating for Brenntag AG (0MPT)
TipRanks Auto-Generated Intelligence Newsdesk5 days agoDec 09, 2025

In a report released today, Chris Counihan from Jefferies maintained a Sell rating on Brenntag AG, with a price target of €42.00. According to TipR......

BioNTech and OncoC4 Report Positive Phase 3 Trial Results for Gotistobart in Lung Cancer
TipRanks Auto-Generated Newsdesk6 days agoDec 08, 2025

BioNTech SE ( ($BNTX) ) has provided an update. On December 6, 2025, BioNTech SE and OncoC4, Inc. presented promising data from the non-pivotal dos......

BioNTech Satisfies Minimum Condition in CureVac Exchange Offer
TipRanks Auto-Generated Newsdesk10 days agoDec 03, 2025

BioNTech SE ( ($BNTX) ) has issued an update. On December 3, 2025, BioNTech SE announced that it has satisfied the minimum condition of its exchang......

Jefferies Sticks to Their Buy Rating for BioNTech SE (BNTX)
TipRanks Auto-Generated Intelligence Newsdesk10 days agoDec 03, 2025

Jefferies analyst Akash Tewari maintained a Buy rating on BioNTech SE today and set a price target of $151.00. Tewari covers the Healthcare sector,......

Benitec Biopharma Concludes 2025 Annual Stockholders Meeting
TipRanks Auto-Generated Newsdesk11 days agoDec 02, 2025

Benitec Biopharma ( ($BNTC) ) has shared an update. On December 1, 2025, Benitec Biopharma Inc. held its virtual 2025 Annual Meeting of Stockholder......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 15 articles.

ABCD
1SymbolPriceChangeVol
2BNT$45.77-1.6%53.07K
3
4
5
6

Get Brookfield Wealth Solutions Ltd. Class A Exchangeable Limited Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.